4.6.2.3Vertical
Oncology Home Infusion
Specialized infusion providers delivering chemotherapy at home.
Market snapshot
These figures describe Home Infusion Therapy (4.6.2), the segment that Oncology Home Infusion sits within — not Oncology Home Infusion on its own.
FragmentationConsolidatingEstimate
No discrete Census NAICS code under home health — home infusion spans home health (621610) and pharmacy classifications, so the segment is not separately sized here.
Business model & economics
Revenue model
Drug margin plus nursing and infusion-service fees
Key economics
- Recurring revenue
- Moderate–High
- EBITDA margin
- Drug-margin- and mix-dependent
- Capex intensity
- Moderate
recurring chronic infusion
Characteristics
- Shift of infusion from hospital to home and ambulatory.
- Specialty and biologic drug growth.
- Combines pharmacy, nursing, and logistics.
M&A deal context
Deal activityModerate
Who’s acquiring
- Home-infusion & specialty-pharmacy platforms
- Pharmacy strategics
- PE-backed consolidators
What’s driving deals
- Site-of-care shift to home infusion.
- Specialty-drug growth.
- Consolidation of capability-intensive providers.
Find Oncology Home Infusion acquisition targets
Search Acquisera’s index for companies classified under Oncology Home Infusion (4.6.2.3) and build a targeted deal pipeline.
Search companies